Ovid Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.43

+0.03 (+1.25%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,588.9% upside

Low Target $30.97

Average Target $41.04

High Target $66.83

Current Price $2.43

Current
$2.43

Target
$41.04

$30.97 $41.04 avg $66.83

Scenario Analysis

Bear Case

$30.97

1,174.5%

Low target

Base Case

$41.04

+1,588.9%

Avg target

Bull Case

$66.83

+2,650.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$3.11

-21.7% from high

52-Week Low

$0.27

+799.7% from low

Target vs 52W High

$41.04

+1,221.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+20.5%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.2%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+178.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.1%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-88.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-23.9%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.0%